Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding

Allergy. 2021 Mar;76(3):878-883. doi: 10.1111/all.14523. Epub 2020 Aug 27.

Pia Gattinger¹, Kristina Borochova¹, Yulia Dorofeeva¹, Rainer Henning², Renata Kiss², Bernhard Kratzer³, Bernhard Mühl⁴, Thomas Perkmann⁵, Doris Trapin³, Martina Trella⁵, Paul Ettel³, Inna Tulaeva^{1

6}, Winfried F Pickl³, Rudolf Valenta^{1

6

7

8}

¹ Department of Pathophysiology and Allergy Research, Division of Immunopathology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
² Viravaxx, Vienna, Austria.
³ Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
⁴ Labors.at, Vienna, Austria.
⁵ Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
⁶ Laboratory for Immunopathology, Department of Clinical Immunology and Allergy, Sechenov First Moscow State Medical University, Moscow, Russia.
⁷ NRC Institute of Immunology FMBA of Russia, Moscow, Russia.
⁸ Karl Landsteiner University of Health Sciences, Krems, Austria.

No abstract available

Keywords: COVID-19; SARS-CoV-2; immune complex; molecular interaction assay; protective antibodies; vaccine.

Publication types